NCT00896454 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 33
- units
- Participants
- groups
- description
- Participants received denosumab at a dose of 120 mg subcutaneously (SC) every 4 weeks (Q4W) with a loading dose of 120 mg SC on study Days 8 and 15.
- id
- BG000
- title
- Denosumab
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.8
- value
- 60.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- Female
- measurements
- group Id
- BG000
- value
- 21
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- 4
- description
- Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about \> 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair \> 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Bladder
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Breast
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Head and neck
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Liver
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Neuroendocrine/carcinoid
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Non-hodgkin's
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Non-small cell lung cancer
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Ovarian
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Renal
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Small cell lung cancer
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Soft tissue sarcoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown (primary tumor)
- param Type
- NUMBER
- title
- Primary Tumor Type
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 68.8
- value
- 56.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time from initial cancer diagnosis to enrollment
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 30
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No
- param Type
- NUMBER
- title
- Presence of metastatic disease at enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- No
- param Type
- NUMBER
- title
- Presence of bone metastatic disease at enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Fatigue
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Anorexia
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Nausea
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Depressed level of consciousness
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Vomiting
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Dry mouth
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Constipation
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Lethargy
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Confusion
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Polyuria
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Abdominal pain
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Decreased mental acuity
- description
- Participants may have had more than one symptom
- param Type
- NUMBER
- title
- Baseline Hypercalcemia of Malignancy (HCM) Symptoms
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.27
- value
- 13.89
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Calcium (corrected)
- unit Of Measure
- mg/dL
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 33
- units
- Participants
- groups
- description
- Participants received denosumab at a dose of 120 mg subcutaneously (SC) every 4 weeks (Q4W) with a loading dose of 120 mg SC on study Days 8 and 15.
- id
- BG000
- title
- Denosumab
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.8
- value
- 60.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- Female
- measurements
- group Id
- BG000
- value
- 21
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- 4
- description
- Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about \> 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair \> 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Bladder
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Breast
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Head and neck
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Liver
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Neuroendocrine/carcinoid
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Non-hodgkin's
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Non-small cell lung cancer
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Ovarian
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Renal
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Small cell lung cancer
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Soft tissue sarcoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown (primary tumor)
- param Type
- NUMBER
- title
- Primary Tumor Type
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 68.8
- value
- 56.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time from initial cancer diagnosis to enrollment
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 30
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No
- param Type
- NUMBER
- title
- Presence of metastatic disease at enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- No
- param Type
- NUMBER
- title
- Presence of bone metastatic disease at enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Fatigue
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Anorexia
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Nausea
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Depressed level of consciousness
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Vomiting
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Dry mouth
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Constipation
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Lethargy
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Confusion
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Polyuria
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Abdominal pain
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Decreased mental acuity
- description
- Participants may have had more than one symptom
- param Type
- NUMBER
- title
- Baseline Hypercalcemia of Malignancy (HCM) Symptoms
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.27
- value
- 13.89
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Calcium (corrected)
- unit Of Measure
- mg/dL
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle